Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.

Abstract

Etanercept did not affect the pathergy reaction and the cutaneous response to MSU crystals. However, the drug was effective in suppressing most of the mucocutaneous manifestations of BD.